The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling
Abstract
Retinoic acid-inducible gene I (RIG-I) is a key pattern recognition receptor that senses viral RNA and interacts with the mitochondrial adaptor MAVS, triggering a signaling cascade that results in the production of type I interferons (IFNs). This signaling axis is initiated by K63-linked ubiquitination of RIG-I mediated by the E3 ubiquitin ligase TRIM25, which promotes the interaction of RIG-I with MAVS. USP15 was recently identified as an upstream regulator of TRIM25, stabilizing the enzyme through removal of degradative K48-linked polyubiquitin, ultimately promoting RIG-I-dependent cytokine responses. Here, we show that the E6 oncoprotein of human papillomavirus type 16 (HPV16) as well as of other HPV types form a complex with TRIM25 and USP15 in human cells. In the presence of E6, the K48-linked ubiquitination of TRIM25 was markedly increased, and in line with this, TRIM25 degradation was enhanced. Our results further showed that E6 inhibited the TRIM25-mediated K63-linked ubiquitination of RIG-I and its CARD-dependent interaction with MAVS. HPV16 E6, but not E7, suppressed the RIG-I-mediated induction of IFN-β, chemokines, and IFN-stimulated genes (ISGs). Finally, CRISPR-Cas9 gene targeting in human keratinocytes showed that the TRIM25-RIG-I-MAVS triad is important for eliciting an antiviral immune response to HPV16 infection. Our study thus identifies a novel immune escape mechanism that is conserved among different HPV strains and further indicates that the RIG-I signaling pathway plays an important role in the innate immune response to HPV infection. IMPORTANCE Persistent infection and tumorigenesis by HPVs are known to require viral manipulation of a variety of cellular processes, including those involved in innate immune responses. Here, we show that the HPV E6 oncoprotein antagonizes the activation of the cytoplasmic innate immune sensor RIG-I by targeting its upstream regulatory enzymes TRIM25 and USP15. We further show that the RIG-I signaling cascade is important for an antiviral innate immune response to HPV16 infection, providing evidence that RIG-I, whose role in sensing RNA virus infections has been well characterized, also plays a crucial role in the antiviral host response to small DNA viruses of the Papillomaviridae family.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“High-risk E6 proteins can also attenuate Retinoic acid-inducible gene I (RIG-I)-mediated signalling by promoting ubiquitination and degradation of TRIM25, an activator of RIG-I signalling, thus dampening type-I interferon production [354].”
From The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis (2021) · cites this paper as [354]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T., Ishii, K. J., et al. (2006) · Nature · doi:10.1038/nature04734 · Cited by 3,888
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction
Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K. J., Takeuchi, O., & Akira, S. (2005) · Nature Immunology · doi:10.1038/ni1243 · Cited by 2,562
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R., & Tschopp, J. (2005) · Nature · doi:10.1038/nature04193 · Cited by 2,401
RIG-I-mediated antiviral responses to single-stranded RNA bearing 5’-phosphates
Pichlmair, A., Schulz, O., Tan, C. P., Näslund, T. I., Liljeström, P., Weber, F., & Reis e Sousa, C. (2006) · Science · doi:10.1126/science.1132998 · Cited by 2,210
Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5'-diphosphates
Goubau, D., Schlee, M., Deddouche, S., Pruijssers, A. J., Zillinger, T., Goldeck, M., Schuberth, C., Van der Veen, A. G., Fujimura, T., Rehwinkel, J., et al. (2014) · Nature · doi:10.1038/nature13590 · Cited by 557
White, E. A., Sowa, M. E., Tan, M. J. A., Jeudy, S., Hayes, S. D., Santha, S., Münger, K., Harper, J. W., & Howley, P. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116776109 · Cited by 198
Self-citation
Research works printed but not linked: 67
- 10.1016/j.mib.2015.03.001 · DOI
- 10.1016/j.cell.2010.01.022 · DOI · Paper page
- 10.1126/science.1132505 · DOI · Paper page
- 10.1016/j.virol.2015.03.013 · DOI
- Paz S, Sun Q, Nakhaei P, Romieu-Mourez R, Goubau D, Julkunen I, Lin R, Hiscott J. 2006. Induction of IRF-3 and IRF-7 phosphorylation following activation of the RIG-I pathway. Cell Mol Biol (Noisy-le-Grand) 52:17–28.
- 10.1016/j.cell.2005.08.012 · DOI · Paper page
- 10.1016/j.molcel.2005.08.014 · DOI
- 10.1016/j.it.2016.10.008 · DOI
- 10.1073/pnas.0804947105 · DOI
- 10.1038/nature05732 · DOI
- 10.1016/j.immuni.2012.03.022 · DOI
- 10.1038/nature13140 · DOI
- 10.1016/j.celrep.2016.06.070 · DOI
- 10.1016/j.molcel.2010.12.029 · DOI · Paper page
- 10.1126/scisignal.2004577 · DOI
- 10.1128/JVI.00605-09 · DOI
- 10.1016/j.vaccine.2012.06.083 · DOI
- 10.1515/hsz-2017-0113 · DOI · Paper page
- 10.1016/j.coviro.2015.09.001 · DOI
- 10.1002/path.4496 · DOI
- 10.1038/nrc2886 · DOI
- 10.1002/j.1460-2075.1989.tb08570.x · DOI · Paper page
- 10.1128/jvi.63.10.4417-4421.1989 · DOI · Paper page
- 10.1016/0092-8674(93)90384-3 · DOI · Paper page
- Boyer SN, Wazer DE, Band V. 1996. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res 56:4620–4624.
- 10.1128/JVI.00881-07 · DOI · Paper page
- 10.1128/mBio.01530-16 · DOI · Paper page
- 10.1089/jir.2009.0075 · DOI
- 10.1016/j.virusres.2016.11.004 · DOI
- 10.1016/j.virusres.2016.11.023 · DOI
- 10.4049/jimmunol.178.5.3186 · DOI
- 10.1126/science.aab3291 · DOI · Paper page
- 10.1371/journal.pone.0017848 · DOI
- 10.1038/nrmicro.2016.45 · DOI
- 10.1016/j.virol.2013.04.026 · DOI
- 10.1016/j.cub.2005.05.059 · DOI
- 10.1126/science.1323879 · DOI
- 10.1016/j.virol.2004.02.011 · DOI
- 10.1371/journal.ppat.1003384 · DOI
- 10.1038/nature00826 · DOI
- 10.1042/BSR20170805 · DOI
- 10.1038/onc.2015.21 · DOI
- 10.1038/srep19070 · DOI
- 10.1002/ijc.31027 · DOI
- 10.1371/journal.ppat.1004466 · DOI
- 10.1128/JVI.74.9.4174-4182.2000 · DOI
- 10.1074/jbc.275.10.6764 · DOI · Paper page
- Perea SE, Massimi P, Banks L. 2000. Human papillomavirus type 16 E7 impairs the activation of the interferon regulatory factor-1. Int J Mol Med 5:661–666.
- 10.1128/JVI.05279-11 · DOI · Paper page
- 10.1101/gad.12.13.2061 · DOI · Paper page
- 10.1016/j.immuni.2013.05.007 · DOI
- 10.1016/j.it.2016.12.004 · DOI
- 10.1128/JVI.00748-16 · DOI
- 10.1038/ni.1779 · DOI
- 10.1016/j.cell.2009.06.015 · DOI
- 10.1099/vir.0.005389-0 · DOI
- 10.1016/j.chom.2016.10.011 · DOI
- 10.1038/s41590-017-0005-y · DOI
- 10.1128/JVI.01197-14 · DOI
- 10.1128/JVI.02172-12 · DOI · Paper page
- 10.1371/journal.ppat.1005701 · DOI
- 10.1128/JVI.00487-12 · DOI
- 10.1128/JVI.02241-09 · DOI
- 10.1007/978-1-4939-2013-6_24 · DOI
- 10.1128/JVI.00731-09 · DOI
- 10.1371/journal.pone.0022427 · DOI
- 10.1371/journal.pone.0016405 · DOI
Cited by
Lee (2019) · doi:10.1038/s12276-019-0299-y · Cited by 635
Basukala, O., & Banks, L. (2021) · Viruses · doi:10.3390/v13101892 · Cited by 137
Metadata
- Authors
- Chiang, C., Pauli, E.-K., Biryukov, J., Feister, K. F., Meng, M., White, E. A., Münger, K., Howley, P. M., Meyers, C., & Gack, M. U.
- Affiliations
- Department of Microbiology, The University of Chicago, Chicago, Illinois, USA
- Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts, USA
- Department of Microbiology and Immunology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA
- Department of Otorhinolaryngology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
- Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, USA
- ORCID
- Gack, Michaela U.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2018-03-15
- Volume
- 92
- Issue
- 6
- ISSN
- 0022-538X
- 1098-5514
- Cited by
- 140
- References
- 6
- Language
- en
- Funders
- The Alexander & Margaret Stewart Trust Foundation
- German Research Foundation (PA2090/1-1)
- HHS | National Institutes of Health (CA197262, CA066980)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI087846)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review